Shop

Author at Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Press Releases

24 May 2024

8 Above and award-winning filmmaker Jon Reiss announce the launch of the groundbreaking podcast Plantscendence

8 Above and award-winning filmmaker and author Jon Reiss announced the launch of the groundbreaking podcast Plantscendence. Join Reiss on a transformative journey as he explores the world of psychedelics...

By Microdose

Events

21 Nov 2023

Wonderland 2023 Review: PsychMD

With Wonderland 2023 still fresh in our rear-view mirrors, let’s take a moment to look at some of the highlights from the big event....

By Microdose

Culture

6 Nov 2023

Wonderland and Kandyflip.Art Present Art Auction Featuring Rare Graffiti Art From Renowned Artists

Wonderland and Kandyflip.Art Present Art Auction Featuring Rare Graffiti Art From Renowned Artists...

By Microdose

Events

2 Nov 2023

Microdose Announces Dr. Sam Clark, CEO of Terran Biosciences, as Wonderland 2023 Keynote Presenter

In addition to presenting a Keynote address, Dr. Clark will lead a workshop and speak on two panels:at Wonderland 2023....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Culture

17 Oct 2023

Honoring Roland Griffiths: Psychedelic Pioneer

The psychedelic medicine community has lost one of its great figures as Dr. Roland Griffiths has passed away....

By Microdose

Industry

13 Sep 2023

The Longevity+DeSci Summit: Advancing the Frontiers of Longevity Science

The Microdose team attended the Longevity+DeSci Summit NYC, held on August 10-11, 2023. This groundbreaking conference brought together leaders in aging research, biotechnology, and decentralized science. Organized by the nonprofit...

By Microdose

Culture

6 Sep 2023

Ethical Concerns in Psychedelic Therapy

A deeper look at some of the ethical concerns in the psychedelic medicine space and how to best address them....

By Microdose

Health & Wellness

30 Aug 2023

Psychedelic Navigators: The Crucial Role of Guides and Therapists

Psychedelics can be powerful tools for healing. But as they say in the comics, with great power comes great responsibility. Which is why psychedelic practitioners — guides and therapists —...

By Microdose

Industry

28 Aug 2023

Using Virtual Reality for Innovation and Safer Psychedelic Experiences

VR can be used to help prepare for psychedelic therapy, guide them through the journey, and help them integrate experiences....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.